logo
logo
DH stock ticker logo

Definitive Healthcare Corp.

NASDAQ•DH
CEO: Mr. Kevin D. Coop
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Listing Date: 2021-09-15
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Contact Information
492 Old Connecticut Path, Suite 401, Framingham, MA, 01701, United States
508-720-4224
www.definitivehc.com
Market Cap
$98.88M
P/E (TTM)
-0.7
37.8
Dividend Yield
--
52W High
$4.70
52W Low
$0.92
52W Range
1%
Rank61Top 91.5%
2.0
F-Score
Modified Piotroski Analysis
Based on 6-year fundamentals
Weak • 2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2020-2025

Financial Dashboard

Q4 2025 Data

Revenue

$61.53M+0.00%
4-Quarter Trend

EPS

-$0.09+0.00%
4-Quarter Trend

FCF

-$1.72M+0.00%
4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Revenue Declined 4.0% Total revenue $241.5M USD, down $10.7M versus prior year; driven by lower subscription revenue across all customer types.
Net Loss Significantly Reduced Net loss narrowed to $(199.3M) USD from $(591.4M) USD, reflecting $392.1M improvement in bottom line results for the year.
Goodwill Impairment Decreased Goodwill impairment charge dropped $492.8M USD to $196.1M USD, significantly lowering total operating expenses for the fiscal year.
Positive Operating Cash Flow Cash provided by operating activities totaled $53.8M USD, supporting liquidity despite overall net loss for the reporting period.

Risk Factors

Customer Retention Rate Dropped Total Net Dollar Retention Rate fell 4 points to 81% for 2025, indicating pressure on existing customer expansion and increased churn.
Remaining Performance Obligations Down Total RPO decreased $53.3M USD to $240.5M USD, signaling slower recognized revenue growth ahead due to macroeconomic pressures.
Macroeconomic Headwinds Persist Challenging macroeconomic conditions continue elongating sales cycles and impacting new customer acquisition rates across key markets.
Populi Litigation Contingency $3.0M contingent liability recorded due to ongoing litigation with former Populi equity holders over 2024 earn-out metrics.

Outlook

Platform Innovation Focus Growth driven by continued significant investment in engineering and R&D to enhance platform capabilities and expand use cases.
Targeted Customer Acquisition Plans focus on organically growing customer count, emphasizing Enterprise Customers representing the majority of current ARR base.
Evaluate Strategic Acquisitions Management intends to evaluate selective strategic acquisitions and investments to further expand platform breadth and market position.
Managing Executive Transitions Ongoing review of organizational design includes recent executive leadership changes impacting operational focus and attention.

Peer Comparison

Revenue (TTM)

OMI stock ticker logoOMI
$2.76B
-41.0%
TBRG stock ticker logoTBRG
$346.84M
+0.7%
DH stock ticker logoDH
$241.52M
-4.2%

Gross Margin (Latest Quarter)

SPOK stock ticker logoSPOK
117.1%
+19.3pp
EDIT stock ticker logoEDIT
100.0%
+2621.3pp
OMI stock ticker logoOMI
93.9%
-2.1pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
LYEL$521.85M-1.4-90.5%12.3%
NRC$374.86M31.058.5%58.6%
SOPH$336.84M-4.1-117.0%38.6%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
1.3%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow

Deep Research

Next earnings:Apr 30, 2026
|
EPS:$0.03
|
Revenue:$54.99M
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement
LTM
No Data